RCKT - Rocket Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
0
0
0
Operating Expense
83,047
76,151
71,156
26,737
41,879
Operating Income
-83,047
-76,151
-71,156
-26,737
-41,879
Net Non Operating Interest Income Expense
-3,668
-2,544
-4,349
-2,760
-975
Other Income Expense
1,981
1,425
987
-
-
Pretax Income
-84,734
-77,270
-74,518
-29,497
-42,854
Net Income Common Stockholders
-84,734
-77,270
-74,518
-29,497
-42,854
Diluted NI Available to Com Stockholders
-84,734
-77,270
-74,518
-29,497
-42,854
Basic EPS
-
-
-0.0019
-0.0044
-0.0064
Diluted EPS
-
-
-0.0019
-0.0044
-0.0064
Basic Average Shares
-
-
39,378
6,765
6,684
Diluted Average Shares
-
-
39,378
6,765
6,684
Total Operating Income as Reported
-83,047
-76,151
-71,156
-26,737
-41,879
Total Expenses
83,047
76,151
71,156
26,737
41,879
Net Income from Continuing & Discontinued Operation
-84,734
-77,270
-74,518
-29,497
-42,854
Normalized Income
-84,734
-77,270
-74,518
-29,497
-42,854
Interest Income
2,976
3,414
1,690
819
443
Interest Expense
6,644
5,958
6,039
3,579
1,418
Net Interest Income
-3,668
-2,544
-4,349
-2,760
-975
EBIT
-78,090
-71,312
-68,479
-25,918
-41,436
EBITDA
-77,668
-
-
-
-
Reconciled Depreciation
422
426
330
200
169
Net Income from Continuing Operation Net Minority Interest
-84,734
-77,270
-74,518
-29,497
-42,854
Total Unusual Items Excluding Goodwill
-
-
-
-
0
Total Unusual Items
-
-
-
-
0
Normalized EBITDA
-77,668
-70,886
-68,149
-25,718
-41,267
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0